Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-11-02

FDA Approved: NALOXONE HYDROCHLORIDE — Supplemental Application (BPI Labs LLC)

View source ↗

Summary

FDA approved a supplemental application for Naloxone hydrochloride submitted by BPI Labs LLC. This action confirms approval of an additional formulation under t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Naloxone Hydrochloride (Naloxone hydrochloride)

Snippet

SUPPL AP for NALOXONE HYDROCHLORIDE (NALOXONE HYDROCHLORIDE)